Authors: Abstract:

Purpose: To describe the clinical presentation, diagnostic challenges, management, and visual outcome of acute posterior vitreous detachment (PVD) in patients with Fuchs uveitis syndrome (FUS)
Methods: This retrospective case series included consecutive patients with FUS who presented with acute PVD at a referral center from 2020 to 2024. The diagnosis of PVD was established based on fundus examination and dynamic B-scan ultrasonography findings.
Results: Sixteen eyes of 16 patients (11 females, 5 males) with a mean age of 43 ± 9.8 years were studied. All patients reported sudden blurred vision in a white, painless eye, with 43.8% noting a new onset or an increased floater. The mean best-corrected visual acuity (BCVA) ranged from 20/25 to 20/200 at presentation, with an average of 0.43 logMAR. B-scan imaging revealed that following PVD, the majority of echogenic vitreous opacities were confined to the detached, shrunken vitreous body, and in some instances, accumulated within the peripheral vitreous cortex. The liquefied vitreous humor between the retina and the posterior hyaloid remained relatively echo-free. Within 3 months, spontaneous visual improvement occurred in 62.5% of patients, with mean BCVA improving from 0.310 to 0.127 logMAR. In three patients with persistent symptoms, pars plana vitrectomy (PPV) resulted in significant visual improvement, with the mean logMAR changing from 0.740 to 0.133.
Conclusion: Acute PVD in patients with FUS can lead to sudden blurred vision, likely due to the increased density of inflammatory cells, opacities, and condensed vitreous strands within a detached, shrunken vitreous gel. In some cases, inflammatory deposits were layering over the peripheral vitreous body, contributing further to visual disturbance. Although most eyes showed spontaneous improvement, PPV was an effective intervention for patients with persistent, intolerable symptoms.

Keywords: Fuchs Uveitis Syndrome, Posterior Vitreous Detachment

References:

1. Jabs DA, Acharya NR, Chee SP, Goldstein D, McCluskey P, Murray PI, et al.; Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for fuchs uveitis syndrome. Am J Ophthalmol 2021;228:262-267.

2. Sun Y, Ji Y. A literature review on Fuchs uveitis syndrome: An update. Surv Ophthalmol 2020;65:133-143.

3. Bonfioli AA, Curi AL, Orefice F. Fuchs’ heterochromic cyclitis. Semin Ophthalmol 2005;20:143-146.

4. Norrsell K, Sjödell L. Fuchs’ heterochromic uveitis: A longitudinal clinical study. Acta Ophthalmol 2008;86:58-64.

5. Yang P, Fang W, Jin H, Li B, Chen X, Kijlstra A. Clinical features of Chinese patients with Fuchs’ syndrome. Ophthalmology 2006;113:473-480.

6. Hogan MJ. Inflammation and its effect on the vitreous. Trans Ophthalmol Soc U K (1962) 1975;95:378-381.

7. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140:509-516.

8. Levin M, Cohen N. The effects of aging on the mechanical properties of the vitreous. J Biomech 2021;119:110310.

9. Ahmed F, Tripathy K. Posterior vitreous detachment. StatPearls Publishing; 2024.

10. Hikichi T. Time course of development of posterior vitreous detachments after phacoemulsification surgery. Ophthalmology 2012;119:2102-2107.

11. Park Y, Cho KJ. Posterior segment complications of Ahmed valve implantation. BMC Ophthalmol 2022;22:78.

12. Wilkinson CP. Safety of vitrectomy for floaters—How safe is safe? Am J Ophthalmol 2011;151:919-920.e1.

13. Sommerville DN. Vitrectomy for vitreous floaters: Analysis of the benefits and risks. Curr Opin Ophthalmol 2015;26:173-176.

14. Fink S, Kumar JB, Cunningham MA. Small-gauge pars plana vitrectomy for visually significant vitreous floaters. J Vitreoretin Dis 2020;5:247-250.